Clinical Trials Directory

Trials / Completed

CompletedNCT02115607

Subharmonic Imaging and Pressure Estimation for Monitoring Neoadjuvant Chemotherapy

Quantitative Subharmonic Breast Imaging: Subharmonic Imaging and Pressure Estimation for Monitoring Neoadjuvant Chemotherapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
17 (actual)
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · Academic / Other
Sex
Female
Age
21 Years
Healthy volunteers
Not accepted

Summary

This is a diagnostic accuracy study to evaluate if two novel ultrasound (US) techniques, quantitative 3D subharmonic imaging (SHI) and Subharmonic Aided Pressure Estimation (SHAPE), used with an intravenous ultrasound contrast agent (Definity, Lantheus Medical Imaging, Billerica, MA), can track changes in locally advanced breast cancer (LABC) angiogenesis and interstitial fluid pressure (IFP), respectively, by studying women undergoing neoadjuvant chemotherapy before as well as with around 10% and 60% (in part 1) or 30% (in part 2) of the neoadjuvant chemotherapy treatment delivered and after completion of the neoadjuvant chemotherapy treatment. Results will be compared to MRI and pathology.

Conditions

Interventions

TypeNameDescription
DRUGDefinity infusion3 ml of Perflutren Lipid Microspheres (Definity) mixed in 50 ml of saline is infused at a rate of approximately 4ml/min

Timeline

Start date
2014-03-01
Primary completion
2018-05-23
Completion
2018-05-23
First posted
2014-04-16
Last updated
2025-05-06
Results posted
2019-10-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02115607. Inclusion in this directory is not an endorsement.